Emerald Health EMH

Emerald Health Therapeutics Inc. (EMH) announced that it has agreed to purchase hemp bio-mass for CBD extraction from Emerald Health Hemp Inc. (EHH). Emerald Health Hemp Inc. is a subsidiary of Emerald Health Sciences, which owns a 32% stake in Emerald Health Therapeutics. Under the agreement, the company has agreed to purchase roughly 500 acres of hemp chaff from EHH in 2018, and approximately 1,000 acres annually from 2019 to 2022. The hemp will be processed by Factors R&D Technologies Ltd., a division of Factors Group of Nutritional Companies Inc. At the end of the period, EMH has the option to renew the agreement for an additional two years.

Comments

comments